chemotherapy drug

Open accessReview ArticleArticle ID: jro-aid1021Views: 23Download: 19

Investigation of radiation attenuation parameters of some drugs used in Chemotherapy in Wide Energy Region

Ferdi Akman* and Mustafa Recep Kaçal

Published on: 4th August, 2018

OCLC Number/Unique Identifier: 7844574123

Objectives: The aim of this study is to compute the radiation attenuation parameters such as mass attenuation coefficient, linear attenuation coefficient, half value layer, mean free path, and effective atomic number for some selected chemotherapy drugs such as Lomustine, Cisplatin, Carmustine, and Chlorambucil in the energy range from 1 keV to 100 GeV. Materials and Methods: The mass attenuation coefficients were calculated with the help of WinXCOM program. Using the obtained mass attenuation coefficients, other parameters such as linear attenuation coefficient, half value layer, mean free path, and effective atomic number were derived. Results: It is observed that the variations of these parameters with respect to the photon energy show changes in different energy regions. According to the obtained results, Cisplatin has the highest mass attenuation coefficient, linear attenuation coefficient and effective atomic number results among the selected chemotherapy drugs. Moreover, Chlorambucil has the highest half value layer and mean free path results among the selected chemotherapy drugs. Conclusion: The results of this study are useful for applied science fields such as radiation physics, pharmacology, and medical physics. These results may be useful when the selected chemotherapy drugs are used together with radiology.

Cite this Article CrossMark Publons Harvard Library HOLLIS GrowKudos ResearchGate Base Search OAI PMH Academic Microsoft Scilit Semantic Scholar Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat

Abstract DOI: 10.29328/journal.jro.1001021 Read Full Article HTML Read Full Article PDF

Open accessPerspectiveArticle ID: ijbmr-aid1014Views: 53Download: 38

In the pursuit of a new route on acute myeloid leukemia treatment

Suzieonette Mawlong*

Published on: 29th December, 2021

Acute myeloid leukaemia (AML) is the forefront disorder of the bone marrow among others that disrupt the normal production of blood cells and platelets. The bone marrow microenvironment or the bone marrow niche (BM niche) that orchestrates the proliferation and survival of Leukaemic stem cells (LSC) is the reason for relapse after complete remission and also chemotherapy drug resistance. As for most cancers oxidative phosphorylation, a fundamental mitochondrial process of energy production, is under focus for the treatment of AML and a novel strategy of targeting heat shock proteins appears as a promising route for further research.

Abstract DOI: 10.29328/journal.ijbmr.1001014 Read Full Article HTML Read Full Article PDF

Search by University/Institution

Enter your University/Institution to find colleagues at HSPI.

Ensuring author's satisfaction with

Friendly and hassle-free publication process
Less production time of articles
Constructive peer-review
Enhancing journal reputation
Regular feedback system
Quick response to authors' queries

All Issues in 2025

January February March April May June

All Issues in 2024

January February March April May June July August September October November December

All Issues in 2023

January February March April May June July August September October November December

Search Articles by Country

Get all latest articles in all Heighten Science Publications Inc journals by country.

Testmonials

Your service is very good and fast reply, Also your service understand our situation and support us to publication our articles.

Palestine College of Nursing, Khan Younis, Gaza St...

Ayman M Abu Mustafa

Publishing with the International Journal of Clinical and Experimental Ophthalmology was a rewarding experience as review process was thorough and brisk. Their visibility online is second to none as...

Elizabeth Awoyesuku

In 2017, I submitted a manuscript to the journal Archives of Biotechnology and Biomedicine belonging to Heighten Science Publications Corporation. Within one week I already received the response from ...

University of Tubingen, Germany

Yvonne Mast

The service is nice and the time of processing the application is fast.

Department of Neurosurgery, Queen Elizabeth Hospit...

Long Ching

Regarding to be services, we note that are work with high standards of professionalism translated into quick response, efficiency which makes communication accessible. Furthermore, I believe to be muc...

Amélia João Alice Nkutxi

I am glad to submit the article to Heighten Science Publications as it has a very smooth and fast peer-review process, which enables the researchers to communicate their work on time.

Anupam M

In my opinion, you provide a very fast and practical service.

Ahmet Eroglu

“It was a delightful experience publishing my manuscript with the Clinical Journal of Obstetrics and Gynecology. They offered me lots of opportunities I never had from most publishing houses and the...

Asafo Jones

Thank you very much for accepting our manuscript in your journal “International Journal of Clinical Virology”. We are very thankful to the esteemed team for timely response and quick review proces...

Abdul Baset

Once I submitted the manuscript, the response time of the reviewers was very fast. The fine-tuning of the galley proof was likewise prompt. I believe the journal provide a valuable outlet to dissemina...

Alon

Browse by Subjects

Biology Group Journals

Engineering Group Journals

Clinical Group Journals

Medical Group Journals

Help ?

HSPI: We're glad you're here. Please click "create a new Query" if you are a new visitor to our website and need further information from us.

If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."

Submit Article